Ozempic stock price saw a slight pullback of 0.4% to $124.10 as traders booked profits. However, moving average convergence divergence (MACD) remains bullish, and chart analysts believe this minor correction forms part of a healthy uptrend pattern. Alibaba promises increased investment in AI infrastructure, and its stock rises. Shares of Novo Nordisk, the Danish drugmaker behind the popular diabetes and weight-loss drugs Ozempic and Wegovy, plummeted more than 20 percent on Tuesday after it said its sales this year would grow much less than previously expected. Ozempic stock price remains resilient despite sector-wide profit-taking. Trading at $124.30, it is outperforming other weight-loss peers in the S&P Healthcare Index. Investors cite demand durability and pipeline diversification as reasons to hold through potential market dips.
